Skip to content
BY 4.0 license Open Access Published by De Gruyter Open Access June 5, 2020

Changes in the fecal microbiome of the Yangtze finless porpoise during a short-term therapeutic treatment

  • Lei You , Congping Ying , Kai Liu , Xizhao Zhang , Danqing Lin , Denghua Yin , Jialu Zhang and Pao Xu EMAIL logo
From the journal Open Life Sciences

Abstract

The fecal microbiome is an integral part of aquatic mammals, like an inner organ. But we know very little about this inner organ of the threatened aquatic species, Yangtze finless porpoise (YFP). Four YFPs were placed into a purse seine for skin ulceration treatment, and this opportunity was taken to nurse the animals closer. In particular, we collected the feces of the YFPs before and after the paired healing and therapeutic treatment, along with samples of their fish diet and water habitat, to explore the changes in their fecal microbiome. Firmicutes (20.9–96.1%), Proteobacteria (3.8–78.7%), Actinobacteria (0.1–35.0%) and Tenericutes (0.8–17.1%) were the most dominant phyla present in the feces. The proportion of Proteobacteria and Actinobacteria increased after the treatment. Firmicutes showed a significant decrease, and most potential pathogens were absent, which reflected the administration of ciprofloxacin hydrochloride. Moreover, environmental shifts can also contribute to changes in the fecal microbiome. These results indicate that certain microbial interactions can be affected by environmental shifts, dietary changes and health-care treatments, which can also help maintain the internal environment of YFPs. These findings will inform the future enhanced protection and management of endangered YFPs and other vulnerable aquatic animals.

1 Introduction

The Yangtze finless porpoise (Neophocaena asiaeorientalis ssp. asiaeorientalis; YFP) is the only freshwater subspecies of Neophocaena, thus possessing an important biological and ecological niche as a research subject. Since the last century, the population of YFPs has fallen sharply. The species is now extremely endangered, and their distribution shows patchiness [1]. In order to save this flagship species, all levels of the state departments and scientific research institutions have actively been implementing rescue and protection measures. Since the release of five YFPs to Tian-E Zhou Baiji National Natural Reserve in 1990, four YFPs ex situ conservation populations have been established: one in the old channel of Shishou Tian-E Zhou, one in Tongling Tiebanzhou, one in the old channel of Jianli Hewangmiao and one at Anqing Xijiang. Today, and the total number of ex situ YFPs has exceeded 100; thus, this method has been crucial in YFP preservation, breeding, scientific research, etc. At Anqing Xijiang YFP ex situ conservation base, the YFP population was established in November 2016. Up to now, 18 YFPs inhabit the Xijiang River.

Dolphin fecal microbiomes have been shown to reflect their marine environment [2]. At the same time, fecal microbiomes are also affected by many factors. Some scholars have explored the gut microbiome of aquatic mammals such as baleen whale, sperm whale, seal and sea lion [3,4,5,6], but we still know very little about the key factors influencing fecal microbial communities in freshwater aquatic mammals, including YFPs. The classification and function of baleen whales’ fecal microbes are known to be influenced by diet and host species [5]. Similarly, the influential factors of fecal microbiome in sperm whales include dietary and host specificities [4]. Significant differences have been observed in the fecal microbiome of seals among different age groups [6]. Differences in host habitat [7], feeding habits and phylogeny lead to differences in the microbial composition of the distal gut in sea lions [3]. In sum, major determinants affecting the fecal microbiome of marine mammals include age, diet, host species and environment [8]. Additionally, some studies have reported that vitamins and antibiotics also affect the fecal microbiome. Antibiotics, such as ciprofloxacin [9], which are commonly used as human and animal medicine, can easily lead to changes in the fecal microbiome [10]. Vitamins can enhance existing fecal microbiome in mammals and effectively inhibit pathogens [11].

Notably, there have been few studies on the fecal microbiome of YFPs. The fecal microbiome structures of YFPs have been described according to their different living environments (Poyang Lake, Tian-E Zhou Baiji National Natural Reserve and Wuhan Baiji Dolphinarium) [12,13], which indicate that the fecal microbiome of YFPs is affected by their habitat. In contrast, in this study, 16S rRNA gene sequencing analysis was used to find the commonalities and differences in the composition of YFP fecal microbiome before and after a short-term therapeutic treatment, to identify possible influential factors and to explore the existence of potential pathogens.

2 Materials and methods

2.1 Background of animals

In December 2017, the Freshwater Fisheries Research Center began inspecting the population of YFPs in the Xijiang River. During the inspection, small areas of skin on both the head and tail fin of four YFPs were found to have ulcerations, scratches which were attributed to coastal beach rubble approached during predation (Figure 1). After slowly using net to surround four YFPs from outside water to near shore, the animals were safely held and lifted up from water by a specially made stretcher. To protect these injuries from infection by pathogens, a health examination, combining the on-site external application of drug therapy and a feeding regiment, was performed immediately. All four animals were male, and we named them A, B, C and D. According to the body length and the formula derived by Zhang [14], we estimated the age of the four animals afterward (Table 1). The age of YFP A, B, C and D was 10, 4, 13 and 5 years old, respectively.

Figure 1 The typical appearance of YFP before and after treatment. (a) YFP before treatment and (b) YFP after treatment.
Figure 1

The typical appearance of YFP before and after treatment. (a) YFP before treatment and (b) YFP after treatment.

Table 1

Animal description

NameSexOverall length (cm)Body length (cm)Weight (kg)Age (year)Source
AMale16916048.510Xijiang
BMale14914236.34Xijiang
CMale17616657.113Xijiang
DMale15814641.85Xijiang

The whole procedure has two phases: on-site health examination and follow-up treatment. During the health examination, we measured animals’ body length and weight and also collected fecal samples from the intestine. Besides, a mixture of Chinese traditional herbs, Yunnan Baiyao (a famous Chinese patent medicine made of precious herbs, which can relieve blood stasis, promote blood circulation and ease pain and swelling [15]), and erythromycin ointment (the mixture of Yunnan Baiyao and erythromycin ointment in a ratio of 1 to 5) was applied to the wound site, and then drug coating was implemented for half an hour on a large suitable water-soaked sponge pad (Table 2). Then, the animals were released back to water in a purse seine (the water surface area of about 500 m2) temporarily for the follow-up treatment. The whole health examination was carried out by professional veterinarians from beginning to end, and the animals were unharmed and handled safely during the process.

Table 2

Therapeutic treatment information

Drug nameTime of day administeredFunctionSource
08:30 am12:30 pm17:30 pm
Yunnan BaiyaoHealth examinationExternal application, anti-inflammatoryYunnan Baiyao Group Co, Ltd
Erythromycin OintmentHealth examinationExternal application, anti-inflammatoryFuyuan Pharmaceutical Co, Ltd
Ciprofloxacin hydrochloride (mg)4 × 0.254 × 0.25Oral, health careBaiyunshan Pharmaceutical Group Co, Ltd
Multivitamins (particle)4Oral, health careSino-US Shanghai Squibb Pharmaceutical Co, Ltd

The follow-up treatment commenced from 8th February to 5th March and lasted for 25 days. YFPs with abrasions were temporarily fed and observed by animal-care experts while living in a purse seine. Healthy and fresh crucians (bought from Anqing Yichuan Aquaculture Farm) were fed to the YFPs three times a day (8:30 am, 12:30 pm and 5:30 pm) after soaking in 5% salt water for 30 min to inhibit potential pathogens [16]. Each YFP was fed 1–2 kg every time. To prevent infection and promote wound healing, ciprofloxacin hydrochloride tablets (5 days) and multivitamin tablets (25 days) were placed in the mouth of bait fish to be fed to the YFPs on the appropriate days (Table 2).

After aforesaid temporary treatment, all animals were observed to swim normally and to eat steadily. We found that the ulceration of animals had improved remarkably and tended to heal. On the last day, after applying the mixed drugs and conducting the health examination one more time, the YFPs were released into open water.

  1. Ethical approval: The research related to animal use has been complied with all the relevant national regulations and institutional policies for the care and use of animals. The medical examination and the relevant experiments performed in this study were approved by the Anqing Fisheries Bureau of China, the department responsible for the protected area. The research complies with the Aquatic Animal Protection Act promulgated in 1993.

2.2 Sample collection

We collected three kinds of samples during the whole process: feces (intestinal content), water and bait fish. The fecal samples and water samples were collected through the health examination before and after the treatment. The bait fish samples were collected during the follow-up treatment (Table 3).

Table 3

Sample information

GroupSample IDTypeSourceDate of sampling
FH groupA1Intestinal contentYFP-A02/08/2018
FH groupB1Intestinal contentYFP-B02/08/2018
FH groupC1Intestinal contentYFP-C02/08/2018
FH groupD1Intestinal contentYFP-D02/08/2018
FT groupA2Intestinal contentYFP-A03/05/2018
FT groupB2Intestinal contentYFP-B03/05/2018
FT groupC2Intestinal contentYFP-C03/05/2018
FT groupD2Intestinal contentYFP-D03/05/2018
F groupF1FishCA-102/09/2018
F groupF2FishCA-202/22/2018
F groupF3FishCA-303/04/2018
W groupW1WaterWater-102/08/2018
W groupW2WaterWater-203/05/2018

First, during the non-harmful, non-invasive fecal collection, each YFP was kept on a large suitable water-soaked sponge pad and held in a steady position. The anus was cleaned with 70% ethanol. All instruments used in the experiment were sterilized with 75% alcohol and UV treatment, which is also illustrated in the method. Before inserting, we lubricated the head of the hose and cleaned the anal attachment with a sterile cotton swab. Then, the tube was inserted about 20 cm into the anus. The tube was then removed with the feces and cut into sections. The sections were put in a sterilized 2 mL Eppendorf tube and stored at −198°C (liquid nitrogen) until DNA extraction. There were eight fecal samples in total, which were divided into two groups; four representing the free-hunting (FH) group (A1, B1, C1 and D1) collected before the treatment and four representing the feeding treatment (FT) group (A2, B2, C2 and D2) collected after the treatment (Table 3).

Then, we collected one water sample at each health examination individually (W1 and W2): we took 150 mL of water inside purse seine into a sterile bottle and then passed the water through a 0.22 µm filter [17]. The filters were stored in 100% alcohol and were frozen at below −20°C until DNA extraction.

We also collected three bait fish samples during the follow-up treatment (F1, F2 and F3): bait fish was sampled by homogenizing the representative daily animal ration in a commercial food-grade blender, then a subsample of the homogenate was taken [18]. The homogenate was put in a sterilized 2 mL Eppendorf tube and stored at −198°C (liquid nitrogen) until DNA extraction.

2.3 DNA extraction

Total microbial genomic DNA samples were extracted using the DNeasy PowerSoil Kit (QIAGEN, Inc, Netherlands), following the manufacturer’s instructions and stored at −20°C for further analysis. The quantity and quality of extracted DNAs were measured using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and agarose gel electrophoresis, respectively.

2.4 16S rRNA Gene amplicon sequencing

PCR amplification of the bacterial 16S rRNA genes V3–V4 region was performed using universal primers (341F [ACTCCTACGGGAGGCAGCAG] and 806R [GGACTACHVGGGTWTCTAAT]) [19]. Sample-specific 7 bp barcodes were incorporated into the primers for multiplex sequencing. The PCR components contained 5 μL of Q5 reaction buffer (×5), 5 μL of Q5 High-Fidelity GC buffer (×5), 0.25 μL of Q5 High-Fidelity DNA Polymerase (5 U/μL), 2 μL (2.5 mM) of dNTPs, 1 μl (10 µM) of each forward and reverse primer, 2 μL of DNA template and 8.75 μL of ddH2O [20]. Thermal cycling consisted of initial denaturation at 98°C for 2 min, followed by 25 cycles consisting of denaturation at 98°C for 15 s, annealing at 55°C for 30 s and extension at 72°C for 30 s, with a final extension for 5 min at 72°C. PCR amplicons were purified with Agencourt AMPure Beads (Beckman Coulter, Indianapolis, IN, USA) and quantified using the PicoGreen dsDNA Assay Kit (Invitrogen, Carlsbad, CA, USA). After the individual quantification step, amplicons were pooled in equal amounts, and paired-end 2 × 300 bp sequencing was performed using the Illlumina MiSeq platform with MiSeq Reagent Kit v3 at Shanghai Personal Biotechnology Co, Ltd (Shanghai, China). All sequences, generated by high-throughput sequencing, were submitted to NCBI Sequence Read Archive under the accession numbers SRR8517807–SRR8517819.

2.5 Sequence analysis

The Quantitative Insights Into Microbial Ecology (QIIME, v1.8.0) pipeline was employed to process the sequencing data, as previously described [21]. Briefly, raw sequencing reads with exact matches to the barcodes were assigned to respective samples and identified as valid sequences. The low-quality sequences were filtered using the following criteria [22,23]: sequences that had a length of <150 bp, sequences that had average Phred scores of <20, sequences that contained ambiguous bases and sequences that contained mononucleotide repeats of >8 bp. Paired-end reads were assembled using FLASH [24]. After chimera detection, the remaining high-quality sequences were clustered into operational taxonomic units (OTUs) at 97% sequence identity by UCLUST [25]. A representative sequence was selected from each OTU using default parameters. OTU taxonomic classification was conducted by BLAST searching the representative sequences set against the Greengenes Database [26] using the best hit [27]. An OTU table was further generated to record the abundance of each OTU in each sample and the taxonomy of these OTUs. OTUs containing <0.001% of total sequences across all samples were discarded. To minimize the difference of sequencing depth across samples, an averaged, rounded rarefied OTU table was generated by averaging 100 evenly resampled OTU subsets under the 90% of the minimum sequencing depth for further analysis.

The alpha-diversity (the Chao1 estimator, the ACE estimator, Shannon diversity index and the Simpson index) and beta-diversity (principal coordinate analysis [PCoA] based on UniFrac distance [28]) of the samples were calculated by analyzing the species abundance, richness and clustering of samples. Using the Mothur software with the Metastats statistical algorithm [29,30], a pairwise comparison test was performed on the sequence size difference between groups at the phylum and genus levels. The significance of differentiation in microbial structure among groups was assessed by analysis of similarities (ANOSIM) [31,32] using R package “vegan”. P < 0.05 was considered a statistically significant difference. The Circos species relationship analysis was performed using the OmicShare tools (http://www.omicshare.com/tools).

A custom pathogen database was constructed by Apprill et al. [33], which included bacteria that had been identified as both marine mammal pathogens and human bacterial pathogens as recognized by the American Biological Safety Association. By comparing the result with the database, we tried to find the existence of all potential pathogens within the fecal samples of YFPs. Each sequence of uncultured and unclassified bacterial species was compared against the National Center for Biotechnology Information (NCBI) nucleotide collection (non-redundant nucleotide database) using Blastn with default parameters (https://blast.ncbi.nlm.nih.gov/Blast.cgi) on 18 December 2018. Then, we downloaded the 16S-sequence data of the known pathogens’ standard strains from the GenBank® nucleic acid sequence database of NCBI. The evolutionary history of potential pathogen OTUs and downloaded sequences was inferred using the neighbor-joining method [34]. The evolutionary distances were computed using the Kimura 2-parameter method and evolutionary analyses were conducted in MEGA 6.0.6 [35,36].

3 Results

3.1 General analysis of sequences obtained by high-throughput sequencing

To explore the fecal bacteria structure and composition of the four YFPs during the short-term therapeutic treatment, 13 samples were analyzed with Illumina MiSeq. After removing the low-quality reads, a total of 1,148,664 effective high-quality reads were clustered into 1,998 OTUs within the 97% sequence similarity threshold. The number of OTUs at different annotated taxonomic levels is listed in Table 4. The stability of the rarefaction curves indicated that the sampling was reasonably representative, and the sequencing depth was adequate to cover the general bacterial diversity (Figure A1).

Table 4

Number of OTUs at different annotated taxonomic levels

SamplePhylumClassOrderFamilyGenusSpeciesUnclassified
F1241240240218158310
F2227227227210152260
F3248248248229173430
A136236236234779470
A2540540539518215980
B1462462458441136691
B2473473468443128371
C1464464463445205940
C2365365365358162300
D1285285283269139461
D2441441439423131890
W1610608582332170270
W2588587564317150190

Note: The numbers indicate the OTUs that were classified to specific taxonomy level.

3.2 Microbial community composition at the phylum level

The phylogenetic classification of sequences from all samples includes 22 different phyla or groups (Figure 2). In water samples, the dominant phyla were Cyanobacteria (varying from 40.0% to 54.8%), Proteobacteria (24.7–24.8%), Actinobacteria (6.9–12.9%), Bacteroidetes (6.8–11.5%), Verrucomicrobia (2.7–5.4%), Planctomycetes (0.7–3.5%) and Chlamydiae (0.2–1.2%), which represented 97.9–98.2% of the total reads. (The lower number in the bracket represents the least relative abundance in a single sample this phylum can account for, and the higher one indicates the most relative abundance in a single sample. The numbers referred to relative abundance in the bracket below represent the same.) In fish samples, the bacterial communities were dominated by Firmicutes (43.3–72.8%) and Proteobacteria (25.3–55.4%). These phyla were detected in high abundance and accounted for 98.1–98.7% of the total reads. The predominant phyla in the feces of YFPs were Firmicutes (20.9–96.1%), Proteobacteria (3.8–78.7%), Actinobacteria (0.1–35.0%), Fusobacteria (2.3–5.9%) and Tenericutes (0.8–17.1%), which covered 99.5–100.0% of the total reads.

Figure 2 Relative abundance of bacterial phyla in fish, water and intestines. FH group represents feces of animals in the FH group, and FT represents feces of animals under human intervention. F represents fish samples, and W represents water samples.
Figure 2

Relative abundance of bacterial phyla in fish, water and intestines. FH group represents feces of animals in the FH group, and FT represents feces of animals under human intervention. F represents fish samples, and W represents water samples.

A three-dimensional weighted PCoA based on UniFrac distance was obtained to measure the discrepancies and distances among all the samples (Figure 3). Bacterial samples displayed three clear clusters referring to fish, water and feces. With the PCoA, we observed the qualitative difference between each sample of feces. Each sample in the FT group deviates from the original (FH group) to a different degree (Figure 3a). In addition, from the FH group to FT group, we also detected that the tendency of the feces was associated with the fish and water samples (Figure 3b). A clear distinction in the bacterial community structure of different groups was also revealed by ANOSIM (R = 0.7923, P = 0.001).

Figure 3 Weighted PCoA based on UniFrac distance in different groups. (a) Grouped by individual YFPs; (b) grouped by whether the animal obtained the therapeutic treatment. F represents fish samples and W for water samples.
Figure 3

Weighted PCoA based on UniFrac distance in different groups. (a) Grouped by individual YFPs; (b) grouped by whether the animal obtained the therapeutic treatment. F represents fish samples and W for water samples.

3.3 Shared and unique bacteria in fecal microbiome reflect composition shifts during the therapeutic treatment

Figure 4 shows that the fecal microbiome changes at the phylum level throughout the therapeutic treatment. The relative abundance of Firmicutes and Actinobacteria was higher in the FT group than in the FH group, whereas Proteobacteria and Tenericutes were relatively less abundant in the FT group. Among the two YFP groups, the relative abundance of Firmicutes differed significantly (Metastats, P = 0.031182). At the phylum level, both FH and FT groups were composed of seven shared phyla (Figure 5a). At the genus level, the top 10 shared bacterial genera in these two groups were Unclassified_Clostridiaceae, Unclassified_Peptostreptococcaceae, Clostridium, Unclassified_Aeromonadaceae, Mycobacterium, Cetobacterium, Enterobacteriaceae, Unclassified_Clostridiales, Plesiomonas and Epulopiscium (Figure 5b). In particular, Mycobacterium (Actinobacteria) and Phormidium (Proteobacteria) showed significant discrepancies, with P-values of 0.019026 and 0.036923, respectively (Table A1). Unique bacteria also existed in each group. For example, Bacteroidetes and Tenericutes only existed in the FH group, while Cyanobacteria only appeared in the FT group. At the genus level, unclassified_Mycoplasmataceae, Edwardsiella, Acinetobacter, Sarcina and unclassified_Clostridia only existed in the FH group, and Erwinia only appeared in the FT group.

Figure 4 Changes in microbiome phyla of fecal samples throughout the therapeutic treatment: (a) Firmicutes, (b) Proteobacteria, (c) Actinobacteria and (d) Tenericutes.
Figure 4

Changes in microbiome phyla of fecal samples throughout the therapeutic treatment: (a) Firmicutes, (b) Proteobacteria, (c) Actinobacteria and (d) Tenericutes.

Figure 5 The Circos diagram of YFP sample groups: (a) phylum level and (b) genus level. UC represents unclassified. FH group represents feces of animals in the FH group, and FT represents feces of animals under human intervention.
Figure 5

The Circos diagram of YFP sample groups: (a) phylum level and (b) genus level. UC represents unclassified. FH group represents feces of animals in the FH group, and FT represents feces of animals under human intervention.

In addition, the fecal microbiomes varied individually among the four YFPs. For instance, YFP-A and YFP-C shared similarities in microbial composition, as well as discrepancies. At the phylum level, their fecal microbiome showed an increase in Actinobacteria and a reduction in Firmicutes after the treatment. At the genus level, both YFP groups displayed an upward trend of Mycobacterium (Actinobacteria). However, Peptostreptococcaceae (Firmicutes) decreased from 37.94% to 7.05% in YFP-A after the treatment, and it rose significantly from 7.50% to 47.76% in YFP-C. Likewise, Aeromonadaceae (Firmicutes) was slightly augmented, 7.31%, in YFP-A and subtly reduced, 7.98%, in YFP-C after the treatment.

3.4 Identification of potential pathogens

To ensure the health of these YFPs during the short-term holding period, we identified the potential pathogens in all collected fecal samples. Through comparison with the pathogen database [33], 13 potential pathogen genera were screened out (Mycobacterium, Propionibacterium, Bacillus, Streptococcus, Clostridium, Sphingomonas, Edwardsiella, Serratia, Acinetobacter, Pseudomonas, Stenotrophomonas, Helicobacter and Plesiomonas). Then, we further screened the bacteria at species level through the pathogen database and found that there were many uncultured and unclassified species of Mycobacterium. The phylogenetic trees revealed that Mycobacterium species do not contain pathogenicity (Figure A2). Furthermore, we identified 10 potential pathogen species: Clostridium bifermentans, Clostridium difficile, Clostridium botulinum, Clostridium colinum, Clostridium perfringens, Edwardsiella tarda, Helicobacter pylori, Plesiomonas shigelloides, Propionibacterium acnes and Serratia marcescens (Figure 6). As it can be seen from Figure 6, both C. perfringens and P. shigelloides can be detected to various degrees in the total samples. C. difficile and E. tarda only appeared in YFP-D, and E. tarda disappeared after treatment. C. colinum only appeared in YFP-A. H. pylori was detected here in our fecal samples, and similarly, Helicobacter spp. and Helicobacter cetorum had been previously detected in YFP feces in an aquarium [37]. The potential pathogens detected in fish samples are as follows: C. perfringens, P. acnes and S. marcescens. The aforementioned potential pathogens were also detected in water samples, and C. bifermentans was also detected in W2 samples.

Figure 6 Heatmap analysis of potential pathogen genera of all samples. The color of the bar represents the abundance of each bacteria species in all samples. The longitudinal clustering indicates the similarity of all species among different samples.
Figure 6

Heatmap analysis of potential pathogen genera of all samples. The color of the bar represents the abundance of each bacteria species in all samples. The longitudinal clustering indicates the similarity of all species among different samples.

3.5 Microbial diversity increased during the therapeutic treatment

Multiple alpha diversity indices, including the Chao, ACE, Simpson and Shannon indices, were calculated to analyze the microbial community richness and evenness in the bacterial samples (Table 5 and Table A2). The fish and water samples were more diverse than the animal fecal samples. This indicates that the microbial diversity in the feces of the four YFPs was significantly higher after the treatment than before (paired-sample t test, P < 0.05).

Table 5

Alpha diversity indices of microbial communities in fish, water and intestines

GroupSample IDSimpsonChao1ACEShannon
FHA10.93227.00227.004.76
B10.85374.78388.294.02
C10.94253.00254.034.94
D10.73241.00241.003.56
FTA20.87571.53580.534.72
B20.84300.80316.013.74
C20.84505.01522.423.95
D20.90395.44390.974.88
FF10.85495.57502.214.17
F20.46448.23453.602.52
F30.86512.38518.114.52
WW10.96619.69619.626.30
W20.98597.67599.376.70

4 Discussion

At present, the study of fecal microbes in aquatic mammals is relatively unusual [38]. The fecal microbiome plays an integral physiological role in host health, including the production of short-chain fatty acids, the synthesis of vitamins, the regulation of the immune system and the development of the brain [39,40,41,42], which is especially crucial for aquatic mammals like YFPs. Therefore, we took advantage of this short-term therapeutic treatment to explore the changes in the fecal microbiomes of YFPs and the most influential factors of intervention. We focused on the following three factors: water in the holding area, fish diet and health-care drugs including ciprofloxacin hydrochloride and multivitamins.

We found that the fecal microbiome diversity of YFP-B decreased after the treatment, while that of YFP-A, -C and -D showed an uptrend. During the treatment, the animals were treated with short-term ciprofloxacin hydrochloride for 5 days to ensure their safety and avoid wound infection. Generally speaking, the diversity of fecal microbiome of animals will be reduced due to the broad-spectrum bactericidal effect of ciprofloxacin hydrochloride during the treatment period, and the effective period of such antibiotics is about 7 days [43]. Different individuals have different responses to a drug, due to their different constitutions and adaptive adjustment abilities [44]. Similarly, the four YFPs showed different biases in their responses to the drug. Among them, YFP-B may still be affected due to its strong sensitivity to the drug and its inadequate self-adaptability, resulting in a downward trend in its fecal microbiome diversity. At the same time, for the other three YFPs, the diversity of fecal microbiome is on the rise. In addition to its own adaptive regulation ability to drugs, the difference in food intake may also be the cause of the discrepancy. If YFP-A, -C and -D ingested more bait fish than YFP-B during daily feeding, it would also increase the bacterial diversity (average 7.6 kg per day). In a word, after the treatment, the diversity of fecal microbial community of YFP-A, -C and -D increased after adaptive adjustment and stable exogenous intake. YFP-B may have a slight decrease in the diversity compared with that before treatment because of its strong sensitivity to the drugs and inadequate regulation.

The weighted PCoA principal coordinates of the bacterial compositions inside YFPs’ intestine, the water in the holding area and the fish diet were clearly classified into three clusters (Figure 3). This showed that the fecal microbiome of YFPs were relatively stable during the short-term treatment. However, the coordinates from the FT group were more skewed toward the F group than the data from the FH group, which proved that the fecal microbiome changed during the short-term therapeutic treatment. At the phylum level, we found that Firmicutes, Proteobacteria, Actinobacteria and Fusobacteria were the most dominant group of bacteria in the four YFPs. Compared with that in previous studies, Actinobacteria was also the dominant bacteria in feces from YFPs in Tian-E Zhou Baiji National Natural Reserve [12] and Wuhan Baiji Dolphinarium [13]. In contrast, the phylum Deinococcus–Thermus was found in the feces of 12 YFPs in Poyang lake, but was not detected in the individuals in this study [12]. The dominant phylum Bacteroidetes in Poyang lake YFPs has low relative abundance in our samples [12]. In addition, Fusobacteria was detected in our samples and the YFPs in the Dolphinarium [13], while it has not been detected in the intestines of wild YFPs (Poyang Lake [12]). However, whether this finding applies to YFPs in other unstudied habitats is yet to be known. Except for Firmicutes, the dominant fecal microbial bacteria, including Proteobacteria, Fusobacteria and especially Bacteroidetes, differed largely in other non-YFP marine carnivores [38]. For example, the fecal microbes of baleen whales have been shown to be mostly composed of the two phyla Bacteroidetes and Firmicutes [5], while the relative abundance of Bacteroidetes in each YFP sample ranged from 0.05% to nearly 0% in this study. Bacteroidetes is a phylum of Gram-negative bacteria that is found in many different niches [45] and helps maintain a healthy intestinal homeostasis. Previous studies have shown that a high salinity of inhabited water significantly augments the relative abundance of Bacteroidetes [46]. Therefore, unlike baleen whales or other marine carnivores, living in a highly saline ocean environment, it is likely that freshwater habitation may be responsible for the lower content of Bacteroidetes in the intestine of YFPs. These similarities and differences can be a perspective for further study.

During this short-term treatment, the fecal microbiome of the YFPs underwent significant changes within a stable condition. In some cases, the relative abundance of some fecal microbes increased significantly after the manual intervention. For example, the relative abundances of the three phyla, Proteobacteria, Actinobacteria and Fusobacteria, increased after the treatment. We found a large amount of Proteobacteria and a small amount of Actinobacteria among the fish for consumption, which may have led to an increase in the content of the two bacterial phyla in the YFP fecal microbiome after the treatment. In our study, the Fusobacteria is mainly composed of Cetobacterium somerae and unclassified_Cetobacterium. C. somerae is commonly found in the guts of freshwater fish and is capable of producing vitamin B12 [47]. We speculated that the increase in Fusobacteria may help the YFPs satisfy their need for vitamin B12. At the genus level, the relative abundance of Mycobacterium significantly increased from 2.8% to 12.7% after the therapeutic treatment. Due to the presence of 43 potential pathogens in Mycobacterium, we performed a phylogenetic tree analysis of the top 20 OTUs, the 5 significant differences in OTUs and 43 reported potential pathogens (Figure A2). The results show that the OTUs belonging to the YFPs were not on the same branch as the 43 potential pathogens, indicating that none of the Mycobacterium OTUs detected in the YFPs were a previously known potential pathogen, so they may not have even been pathogenic or they may have been less pathogenic. In contrast, the relative abundance of certain fecal microbiome declined. At the phylum level, the relative abundance of Firmicutes decreased significantly from 81.5% to 56.3% after the treatment. This may be related to the 5 days, when ciprofloxacin hydrochloride was administered to the YFPs. Studies have shown that ciprofloxacin hydrochloride can reduce the relative abundance of Firmicutes [48]. Ciprofloxacin hydrochloride also has strong permeability and is not susceptible to drug resistance [49]. It has a broad spectrum of antibacterial activity and has a bactericidal effect on Gram-positive and Gram-negative bacteria, including most pathogens [50]. Therefore, its presence also explains the reduction and cancellation in OTU numbers of potential pathogens, C. colinum, E. tarda and P. acnes. The dose of ciprofloxacin was small, and its lethality is not as strong as penicillin [51]. However, it can be seen from the results that it inhibits most potential pathogens (Figure 6). It can also be seen that C. perfringens had many OTUs across all samples, even being detected in the water samples. C. perfringens prefers to live in the intestines of many warm-blooded animals, including humans, and in warm soils. It can cause common foodborne illnesses and necrotic enteritis through food transmission [52]. Fortunately, its average relative abundance was significantly reduced in the YFPs after the therapeutic treatment (C. perfringens, mean [FH group] = 14706.5, mean [FT group] = 7725.7).

We also found that H. pylori, C. bifermentans, C. difficile and S. marcescens were detected in the feces of YFPs across two separate physical examinations, with their OTU counts almost unchanged. Among them, H. pylori is the cause of a variety of gastrointestinal diseases [53]. Helicobacter spp. was detected in the fecal samples of YFP at the Wuhan Baiji Dolphinarium, after the YFPs were fed with infected catfish [37]. However, H. pylori was not detected in the fish diet and water samples in our study, so we speculate that it might have originated in the wild habitat before arriving at the Anqing Xijiang YFP ex situ conservation base. C. bifermentans can produce both nutrients and toxins in the human body [54]. C. difficile contributes to the normal microbial community in some healthy individuals, but patients with infectious diarrhea are often susceptible to its pathogenic potential [55]. S. marcescens has also been detected in the gastrointestinal or upper respiratory tracts of healthy people [56]. In general, the aforementioned potential pathogens may pose a greater threat to immune-compromised individuals, but they were maintained at a very low level (0–0.08‰) in our four YFPs, and they displayed no pathological effect on their bodies under these circumstances. Therefore, the fecal microbiome of YFPs showed that the animals have the stability to be able to resist the low-abundance of potential pathogens. However, we need to stay alert and prevent the relative abundance of potential pathogens from growing over to a certain extent, thereby affecting the animals’ health [57]. Thus, this result has certain guidance to the work of Anqing Xijiang YFP ex situ conservation base.

The changes in the fecal microorganisms of the YFP also reflected the effects of environmental shifts. The 11 phyla, Firmicutes, Proteobacteria, Cyanobacteria, Actinobacteria, Bacteroidetes, Fusobacteria, Verrucomicrobia, Planctomycetes, Chlamydiae, [Deinococcus–Thermus] and Nitrospirae, in the fecal microbial community of YFP are shared with the water environment, which indicates that the fecal microbiome has a certain connection with the water environment. The living environment was shifted from open water area (Xijiang River, 9 km long) to semi-open water area (the water surface area near shore of about 500 m2). The background of the water environment of the animals did not change, but their range of activity became relatively fixed, so the external interference was minimal. Diet is one of the important factors affecting the fecal microbiome [5]. After the treatment, environmental changes also led to changes in feeding habits: from free predation to artificial feeding. Compared with free predation, artificial feeding makes the feeding sources of animals more stable and more conducive to the stable colonization of fecal microorganisms.

In conclusion, this study shows that the fecal microbiome of the YFPs is affected by environmental change, dietary change and health care during the short-term therapeutic treatment, which reveals that a crucial first step has been taken to understand the microbial communities in the intestine of YFPs and aid to benefit the host development and health. Future studies on the drivers of these common or host-specific fecal microbiomes and their physiological effects will provide further insight into the development and function of the YFP microbiome. This in-depth study of the fecal microbiome of the YFPs establishes an understanding of the healthy relationship between fecal microbes and YFPs, which provides scientific support for the further strengthening of YFP ex situ conservation work and improving the effectiveness of the protective measures.


The first two authors contributed equally to the research.

Phone: +86-510-85557959

Acknowledgments

This study was funded by Fundamental Research Funds for Central Public-Interest Scientific Institution (No. 2018JBFR04 and 2017JBFM10), Restoration of fishery resources in Xiangjiaba reservoir area and the cooperative project for the protection of rare and endemic species of the Yangtze River (F02), and Financial Projects of Jiangsu Province (2016–7). The authors thank Personal Biotechnology Co, Ltd Shanghai, China, for Comparative and Functional Genomics for sequencing.

Appendix

Figure A1 Rarefaction curves of intestinal contents, fish and water samples based on high throughput sequencing.
Figure A1

Rarefaction curves of intestinal contents, fish and water samples based on high throughput sequencing.

Figure A2 Neighbor-Joining tree showing sequences difference between OTUs of YFPs and pathogen species of Mycobacterium. Part A means that OTUs of YFPs in Mycobacterium; part B means OTUs with high significance level before and after the short-term feeding treatment; the remaining 43 branches are pathogens of Mycobacterium according to the data reported before.
Figure A2

Neighbor-Joining tree showing sequences difference between OTUs of YFPs and pathogen species of Mycobacterium. Part A means that OTUs of YFPs in Mycobacterium; part B means OTUs with high significance level before and after the short-term feeding treatment; the remaining 43 branches are pathogens of Mycobacterium according to the data reported before.

Table A1

Significance of differences between FH and FT group microbiomes at the phylum and genus levels.

TaxonomyMean (FH)Variance (FH)Stderr (FH)Mean (FT)Variance (FT)Stderr (FT)p-valueq-value
PhylumFirmicutes0.815230.0161620.0635650.5635580.0741470.136150.0311821
GenusMycobacterium0.0671060.0035250.0296870.4327330.1413260.1879670.0190261
Phormidium0.00010600.0000640000.0369231
Table A2

Alpha diversity indices of microbial communities in fish, water and fecal groups.

GroupSimpsonChao1ACEShannon
FH0.86 ± 0.1273.95 ± 68.06277.58 ± 74.634.32 ± 0.64
FT0.86 ± 0.03443.2 ± 19.51452.48 ± 120.694.32 ± 0.56
F0.72 ± 0.23485.39 ± 33.26491.31 ± 33.613.74 ± 1.07
W0.97 ± 0.01608.68 ± 15.57609.5 ± 14.326.5 ± 0.28
  1. Conflict of interest: The authors state no conflict of interest.

References

[1] Mei Z, Huang SL, Hao Y, Turvey ST, Gong W, Wang D. Accelerating population decline of Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis). Biol Conserv. 2012;153:192–200.10.1016/j.biocon.2012.04.029Search in Google Scholar

[2] Soverini M, Quercia S, Biancani B, Furlati S, Turroni S, Biagi E, et al. The bottlenose dolphin (Tursiops truncatus) faecal microbiota. FEMS Microbiol Ecol. 2016;92:fiw055. 10.1093/femsec/fiw055.Search in Google Scholar PubMed

[3] Bik EM, Costello EK, Switzer AD, Callahan BJ, Holmes SP, Wells RS, et al. Marine mammals harbor unique microbiotas shaped by and yet distinct from the sea. Nat Commun. 2016;7:10516. 10.1038/ncomms10516.Search in Google Scholar PubMed PubMed Central

[4] Erwin PM, Rhodes RG, Kiser KB, Keenanbateman TF, Mclellan WA, Pabst DAJ. High diversity and unique composition of gut microbiomes in pygmy (Kogia breviceps) and dwarf (K. sima) sperm whales. Sci Rep. 2017;7(1):7205. 10.1038/s41598-017-07425-z.Search in Google Scholar PubMed PubMed Central

[5] Sanders JG, Beichman AC, Roman J, Scott JJ, Emerson D, Mccarthy JJ, et al. Baleen whales host a unique gut microbiome with similarities to both carnivores and herbivores. Nat Commun. 2015;6:8285. 10.1038/ncomms9285.Search in Google Scholar PubMed PubMed Central

[6] Smith SC, Andrea C, Dewar ML, Arnould JPY. Age-related differences revealed in Australian fur seal Arctocephalus pusillus doriferus gut microbiota. J Fems Microbiol Ecol. 2013;86:246–55.10.1111/1574-6941.12157Search in Google Scholar PubMed

[7] Sanz M, van Winkelhoff AJ, Herrera D, Dellemijnkippuw N, Simón R, Winkel E. Differences in the composition of the subgingival microbiota of two periodontitis populations of different geographical origin. A comparison between Spain and The Netherlands. Eur J Oral Sci. 2010;108:383–92.10.1034/j.1600-0722.2000.108005383.xSearch in Google Scholar PubMed

[8] Nelson TM, Rogers TL, Brown MV. The gut bacterial community of mammals from marine and terrestrial habitats. PLoS One. 2013;812:e83655. 10.1371/journal.pone.0083655.Search in Google Scholar PubMed PubMed Central

[9] Iizumi T, Taniguchi T, Yamazaki W, Vilmen G, Alekseyenko AV, Gao Z, et al. Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice. Gut Pathog. 2016;8:60. 10.1186/s13099-016-0143-z.Search in Google Scholar PubMed PubMed Central

[10] Iizumi T, Battaglia T, Ruiz V, Perez GP. Gut microbiome and antibiotics. Arch Med Res. 2017;48:727–734.10.1016/j.arcmed.2017.11.004Search in Google Scholar PubMed

[11] Kanhere M, Chassaing B, Gewirtz AT, Tangpricha VJ. Role of vitamin D on gut microbiota in cystic fibrosis. J Steroid Biochem Mol Biol. 2018;175:82–7. 10.1016/j.jsbmb.2016.11.001.Search in Google Scholar PubMed PubMed Central

[12] Mclaughlin RW, Chen MM, Zheng JS, Wang D. Analysis of the bacterial diversity in the fecal material of the endangered Yangtze finless porpoise, Neophocaena phocaenoides asiaeorientalis. Mol Biol Rep. 2012;39:5669–76.10.1007/s11033-011-1375-0Search in Google Scholar PubMed

[13] Wan X, Rui R, Mclaughlin RW, Hao Y, Zheng J, Wang D. Fecal bacterial composition of the endangered Yangtze finless porpoises living under captive and semi-natural conditions. Curr Microbiol. 2015;72:306–14.10.1007/s00284-015-0954-zSearch in Google Scholar PubMed

[14] Zhang XF. Studies on the age determination, growth and reproduction of finless porpoise Neophocaena phochenoides. Acta Hydrobiol Sin. 1992;12:289–98.Search in Google Scholar

[15] Bai YC, Mei LJ, Zuo WG, Zhang Y, Gu CH, Shan YH, Hu J, Dai QG. Response of bacterial communities in coastal mudflat saline soil to sewage sludge amendment. Appl Soil Ecol. 2019;144:107–11.10.1016/j.apsoil.2019.07.007Search in Google Scholar

[16] Liu J, Cai MF, Yang HM, Fu JW, Wu GC, Zhao ZG, et al. Yunnan Baiyao reduces hospital-acquired pressure ulcers via suppressing virulence gene expression and biofilm formation of Staphylococcus aureus. Int J Med Sci. 2019;16(8):1078–88. 10.7150/ijms.33723.Search in Google Scholar PubMed PubMed Central

[17] Kearns PJ, Bowen JL, Tlusty MF. The skin microbiome of cow-nose rays (Rhinoptera bonasus) in an aquarium touch-tank exhibit. Zoo Biol. 2017;36:226–30. 10.1002/zoo.21362.Search in Google Scholar PubMed

[18] Cardona C, Lax S, Larsen P, Stephens B, Hampton-Marcell J, Edwardson CF, et al. Environmental sources of bacteria differentially influence host-associated microbial dynamics. mSystems. 2018;3:e00052-18. 10.1128/mSystems.00052-18.Search in Google Scholar PubMed PubMed Central

[19] Herlemann DP, Labrenz M, Jürgens K, Bertilsson S, Waniek JJ, Andersson AF. Transitions in bacterial communities along the 2000 km salinity gradient of the Baltic Sea. ISME J. 2011;5:1571–9.10.1038/ismej.2011.41Search in Google Scholar PubMed PubMed Central

[20] Suzuki A, Segawa T, Sawa S, Nishitani C, Ueda K, Itou T, et al. Comparison of the gut microbiota of captive common bottlenose dolphins Tursiops truncatus in three aquaria. J Appl Microbiol. 2018;126:31–9. 10.1111/jam.14109.Search in Google Scholar PubMed

[21] Caporaso JGKJ, Stombaugh J, Bittinger K, Bushman FD. QIIME allows analysis of high-throughput community sequencing data. Nat Met. 2010;7:335–6.10.1038/nmeth.f.303Search in Google Scholar PubMed PubMed Central

[22] Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2016;312(5778):1355–9.10.1126/science.1124234Search in Google Scholar PubMed PubMed Central

[23] Chen H, Jiang W. Application of high-throughput sequencing in understanding human oral microbiome related with health and disease. Front Microbiol. 2014;5:508. 10.3389/fmicb.2014.00508.Search in Google Scholar PubMed PubMed Central

[24] Tanja M, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957–63.10.1093/bioinformatics/btr507Search in Google Scholar PubMed PubMed Central

[25] Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–1.10.1093/bioinformatics/btq461Search in Google Scholar PubMed

[26] Desantis TZ, Hugenholtz P, Larsen N, Rojas M, Keller K, Huber T, et al. Greengenes: chimera-checked 16S rRNA gene database and workbench compatible in ARB. Appl Env Microbiol. 2006;72:5069–72.10.1128/AEM.03006-05Search in Google Scholar PubMed PubMed Central

[27] Altschul SF. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389–3402.10.1093/nar/25.17.3389Search in Google Scholar PubMed PubMed Central

[28] Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Env Microbiol. 2007;73:1576–85.10.1128/AEM.01996-06Search in Google Scholar PubMed PubMed Central

[29] Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60. 10.1186/gb-2011-12-6-r60.Search in Google Scholar PubMed PubMed Central

[30] White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol. 2009;5(4):e1000352. 10.1371/journal.pcbi.1000352.Search in Google Scholar PubMed PubMed Central

[31] Clarke KR. Non-parametric multivariate analyses of changes in community structure. Austral Ecol. 1993;18(1):117–43.10.1111/j.1442-9993.1993.tb00438.xSearch in Google Scholar

[32] Warton DI, Wright ST, Wang Y. Distance-based multivariate analyses confound location and dispersion effects. Methods Ecol Evolution. 2012;3(1):89–101. 10.1111/j.2041-210x.2011.00127.x.Search in Google Scholar

[33] Apprill A, Miller CA, Moore MJ, Durban JW, Fearnbach H, Barrettlennard LG. Extensive core microbiome in drone-captured whale blow supports a framework for health monitoring. mSystems. 2017;2:e00119-17. 10.1128/mSystems.00119-17.Search in Google Scholar PubMed PubMed Central

[34] Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evolution. 1987;4:406–25.Search in Google Scholar

[35] Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evolution. 1980;16:111–20.10.1007/BF01731581Search in Google Scholar PubMed

[36] Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evolution. 2013;30:2725–9.10.1093/molbev/mst197Search in Google Scholar PubMed PubMed Central

[37] Mclaughlin RW, Zheng JS, Chen MM, Zhao QZ, Wang D. Detection of Helicobacter in the fecal material of the endangered Yangtze finless porpoise Neophocaena phocaenoides asiaeorientalis. Dis Aquat Org. 2011;95:241.10.3354/dao02364Search in Google Scholar PubMed

[38] Nelson TM, Rogers TL, Carlini AR, Brown MV. Diet and phylogeny shape the gut microbiota of Antarctic seals: a comparison of wild and captive animals. Env Microbiol. 2013;15:1132–45.10.1111/1462-2920.12022Search in Google Scholar PubMed

[39] Besten GD, Eunen KV, Groen AK, Venema K, Reijngoud DJ, Bakker BMJ. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325–40.10.1194/jlr.R036012Search in Google Scholar PubMed PubMed Central

[40] Castro-Mejía JL, Jakesevic M, Fabricius NF, Krych Ł, Nielsen DS, Kot W, et al. Gut microbiota recovery and immune response in ampicillin-treated mice. Res Veterinary Sci. 2018;118:357–64.10.1016/j.rvsc.2018.03.013Search in Google Scholar PubMed

[41] Leblanc JG, Milani C, de Giori GS, Sesma F, Van SD, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24:160–8.10.1016/j.copbio.2012.08.005Search in Google Scholar PubMed

[42] Rochellys DH, Shugui W, Farhana A, Yu Q, Britta BR, Annika S, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci. 2011;108:3047–52.10.1073/pnas.1010529108Search in Google Scholar PubMed PubMed Central

[43] Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro–in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74(2):332–9.10.1016/j.ejpb.2009.11.010Search in Google Scholar PubMed

[44] Burke S, Amin N, Incerti C, Plone M, Watson N. Sevelamer hydrochloride (Renagel®), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics. J Clin Pharmacology. 2011;41(2):193–8.10.1177/00912700122009872Search in Google Scholar PubMed

[45] Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20:593–621.10.1128/CMR.00008-07Search in Google Scholar PubMed PubMed Central

[46] Dehler CE, Secombes CJ, Martin SAM. Seawater transfer alters the intestinal microbiota profiles of Atlantic salmon (Salmo salar L.). Sci Rep. 2017;7:13877. 10.1038/s41598-017-13249-8.Search in Google Scholar PubMed PubMed Central

[47] Tsuchiya C, Sakata T, Sugita H. Novel ecological niche of Cetobacterium somerae, an anaerobic bacterium in the intestinal tracts of freshwater fish. Lett Appl Microbiol. 2010;46:43–8.10.1111/j.1472-765X.2007.02258.xSearch in Google Scholar PubMed

[48] Stewardson AJ, Gaïa N, François P, Malhotra-Kumar S, Delémont C, Tejada BMD, et al. Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota. Clin Microbiol Infect. 2015;21:344.e1-11. 10.1016/j.cmi.2014.11.016.Search in Google Scholar PubMed

[49] Yang J. Fisheries medicine manual. Beijing: Science and Technology Press of China; 1998. p. 179–80.Search in Google Scholar

[50] Meng QX, Yu KK. The diagnosis, prevention and cure for the disease of fish, shrimp, crab and shellfish. Bingjing: Agriculture Press of China; 1996. p. 255–81.Search in Google Scholar

[51] Rashid MU, Zaura E, Buijs MJ, Keijser BJF, Crielaard W, Nord CE, et al. Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods. Clin Infect Dis. 2015;60(Suppl. 2):S77–84. 10.1093/cid/civ137.Search in Google Scholar PubMed

[52] García S. Clostridium perfringens: a dynamic foodborne pathogen. Food Bioprocess Technol. 2011;4:624–30.10.1007/s11947-009-0182-2Search in Google Scholar

[53] Wongphutorn P, Chomvarin C, Sripa B, Namwat W, Faksri K. Detection and genotyping of Helicobacter pylori in saliva versus stool samples from asymptomatic individuals in Northeastern Thailand reveals intra-host tissue-specific H. pylori subtypes. BMC Microbiol. 2018;18:10. 10.1186/s12866-018-1150-7.Search in Google Scholar PubMed PubMed Central

[54] Cox DJ, Holland KT. Nutrition and toxin production by Clostridium bifermentans in relation to sporulation. Spore Res. 1977;6(4):159–82. 10.1016/B978-0-12-078701-2.50015-1.Search in Google Scholar

[55] Warriner K, Xu C, Habash M, Sultan S, Weese SJ. Dissemination of Clostridium difficile in food and the environment: Significant sources of C. difficile community acquired Infection? J Appl Microbiology. 2016;122(3):542–53.10.1111/jam.13338Search in Google Scholar PubMed

[56] Steppberger K, Walter S, Claros MC, Spencker FB, Kiess W, Rodloff AC, et al. Nosocomial neonatal outbreak of Serratia marcescens – analysis of pathogens by pulsed field gel electrophoresis and polymerase chain reaction. Infection. 2002;30:277–81.10.1007/s15010-002-2141-ySearch in Google Scholar PubMed

[57] Pei C, Lei XY, Yuan XP, Wang D, Zhao QZ, Zhang QY. Herpes-like virus infection in yangtze finless porpoise (Neophocaena phocaenoides): pathology, ultrastructure and molecular analysis. J Wildl Dis. 2012;48(1):235–7.10.7589/0090-3558-48.1.235Search in Google Scholar PubMed

Received: 2019-08-29
Revised: 2020-02-15
Accepted: 2020-02-18
Published Online: 2020-06-05

© 2020 Lei You et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 25.4.2024 from https://www.degruyter.com/document/doi/10.1515/biol-2020-0032/html
Scroll to top button